Hyperbaric oxygen therapy restores tissue oxygenation and accelerates healing in chronic venous stasis ulcers
Hyperbaric oxygen therapy restores tissue oxygenation and accelerates healing in chronic venous stasis ulcers
Understanding venous stasis ulcers and how HBOT addresses the tissue hypoxia that prevents healing
Venous stasis ulcers (also called venous leg ulcers or stasis ulcers) are the most common type of chronic leg wound, accounting for approximately 70% of all leg ulcers. They develop as a complication of chronic venous insufficiency (CVI), a condition in which damaged or incompetent venous valves allow blood to pool in the veins of the lower legs, generating chronic venous hypertension.
Over time, elevated venous pressure causes capillary leakage, pericapillary fibrin deposition and progressive tissue damage in the lower leg skin and subcutaneous tissue — a process called lipodermatosclerosis. This creates the characteristic indurated, hyperpigmented “gaiter zone” skin of chronic venous insufficiency that is vulnerable to breakdown and ulceration from even minor trauma. Once the skin breaks down, the resulting wound finds itself in severely hypoxic, inflamed tissue that lacks the metabolic capacity to heal.
Standard venous ulcer management centers on compression therapy to reduce venous hypertension, wound dressings to manage the wound environment and control infection, and venous surgery or ablation in appropriate candidates to reduce the underlying pressure. Despite these measures, venous ulcers are notoriously slow to heal — median healing times of 12 to 24 weeks are common, and a significant proportion remain open for years or recur repeatedly.
HBOT addresses the fundamental obstacle to venous ulcer healing — tissue hypoxia in the wound bed. By delivering dissolved oxygen to peri-wound tissue via plasma diffusion, HBOT bypasses the compromised microcirculation to restore the oxygen needed for fibroblast activity, collagen synthesis, immune killing and angiogenesis. Multiple controlled studies confirm that HBOT accelerates venous ulcer healing and improves closure rates in wounds that have stalled with conventional care.
Shallow wound on the lower leg (typically between knee and ankle) with irregular, sloping edges
Moderate to heavy wound exudate, often with surrounding maceration
Surrounding skin that is hyperpigmented (brownish discoloration), indurated or fibrotic (lipodermatosclerosis)
Leg swelling (edema) that worsens with prolonged standing or sitting
Aching, heaviness or pain in the affected leg, typically worse at end of day
Wound that fails to show meaningful progress after 4 to 12 weeks of appropriate compression therapy and wound care
How HBOT breaks the cycle of hypoxia and impaired healing in venous ulcers
Venous stasis ulcers create a self-perpetuating cycle of tissue hypoxia, impaired immune function and failed healing. HBOT addresses each element of this cycle simultaneously.
Restores tissue oxygen to the chronically hypoxic wound bed
Stimulates new blood vessel growth in ischemic tissue
Reduces wound infection risk
Accelerates collagen synthesis and wound closure
Reduces peri-wound edema and inflammation
Supports skin graft take in surgically managed ulcers
For Providers
Clinical evidence for HBOT in venous stasis ulcers
HBOT for venous stasis ulcers is supported by randomized controlled trial data and Cochrane systematic review evidence, providing a solid foundation for its use in wounds that have failed standard care.
Hammarlund and Sundberg — RCT in chronic leg ulcers (1994): This landmark randomized, double-blind, placebo-controlled trial, published in Plastic and Reconstructive Surgery, demonstrated that HBOT significantly accelerated healing in chronic leg ulcers compared to sham treatment. At 6 weeks, patients receiving HBOT showed 35% greater wound area reduction on average, with higher rates of complete wound closure. This study included both venous and mixed venous/arterial ulcers, establishing the foundational RCT evidence for HBOT in chronic leg wounds. [Hammarlund C, Sundberg T. Plast Reconstr Surg. 1994;93(4):829–834. PMID: 8134481]
Kranke et al. — Cochrane systematic review (2012): The Cochrane review of HBOT for chronic wounds examined 12 randomized trials involving patients with diabetic, venous and other chronic wounds. The review found evidence supporting HBOT for accelerating wound healing compared to standard care, with the clearest evidence in populations with lower-extremity wounds and tissue hypoxia. The reviewers noted that the evidence was promising but called for larger trials. [Kranke P et al. Cochrane Database Syst Rev. 2012;4:CD004123. PMID: 22513920]
Transcutaneous oxygen monitoring as predictor: Studies consistently demonstrate that peri-wound tissue oxygen tension (TcPO2) measured during HBOT is the strongest predictor of wound healing response. Wounds achieving TcPO2 above 200 mmHg during HBOT show significantly better healing outcomes than those that do not, providing an objective basis for patient selection and treatment adequacy assessment. We use TcPO2 monitoring to confirm treatment is effective for each individual patient. [Fife CE et al. Wound Repair Regen. 2007;15(6):847–855. PMID: 18028134]
Angiogenesis mechanism: HBOT-mediated angiogenesis in ischemic leg tissue is well-documented. HBOT upregulates VEGF and HIF-1α, stimulating capillary sprouting into the wound bed and progressively restoring tissue perfusion beyond what venous pressure reduction alone can achieve. This new capillary network persists after HBOT ends, providing a lasting improvement in wound bed oxygenation that maintains healing momentum. [Thom SR et al. Am J Physiol Heart Circ Physiol. 2011;300(1):H294–305. PMID: 21057048]
Our venous stasis ulcer HBOT protocol at Bay Area Hyperbarics
HBOT for venous stasis ulcers is most effective when used alongside optimized compression therapy — the cornerstone of venous ulcer management — and appropriate wound care dressings. It is not a substitute for venous surgery or compression where these are indicated, but a powerful adjunct for wounds that have stalled despite adequate conventional management.
Vascular assessment and wound care team coordination
Our medical team reviews your venous insufficiency history, ankle-brachial index, wound characteristics (size, depth, bacterial burden, duration), compression therapy adherence and prior wound care interventions. We coordinate with your vascular surgeon and wound care specialist to integrate HBOT into a comprehensive wound management plan that includes optimized compression and wound care dressings.
HBOT sessions to restore wound bed oxygenation and stimulate healing
You breathe 100% oxygen at 2.0 to 2.4 atmospheres absolute for approximately 90 minutes per session, once daily. Venous ulcer protocols typically involve 30 to 40 sessions as an initial course, with wound response assessment at completion. Transcutaneous oximetry (TcPO2) measurements confirm that tissue oxygen is reaching therapeutic levels.
Wound healing monitoring and recurrence prevention
We track wound area, depth, granulation tissue quality, peri-wound skin condition and patient-reported outcomes throughout treatment. Following wound closure, we work with your vascular team to optimize compression therapy and other measures to prevent recurrence, which is common in chronic venous insufficiency.
Frequently Asked Questions
Answers to the questions patients with venous stasis ulcers most often ask about hyperbaric oxygen therapy.
No — compression therapy remains the cornerstone of venous ulcer management and is not replaced by HBOT. Compression reduces the venous hypertension that drives wound pathology, while HBOT addresses the tissue-level oxygen deficit that prevents healing despite adequate venous pressure management. The two approaches are complementary: HBOT is most beneficial in patients who are already on optimized compression therapy but whose wounds are not progressing at an adequate rate.
Non-healing venous ulcer? Ask us how HBOT can help
Bay Area Hyperbarics provides HBOT for chronic venous stasis ulcers that have not responded to compression therapy and standard wound care. Our team coordinates with your vascular surgeon or wound care specialist to deliver HBOT as part of a comprehensive wound management plan. Call us to discuss your wound and whether HBOT may help.
